Immune checkpoint inhibitor-induced refractory polyarthritis rapidly improved by sarilumab and monitoring with joint ultrasonography: A case report.
Kazuya AbeYuichi IshikawaMichio FujiwaraHiroko YukawaTakeshi YanagiharaSaori TakeiHitoshi AriokaYasuhiko KitaPublished in: Medicine (2022)
Sarilumab may serve as a good treatment option for treating refractory ICI-induced polyarthritis. Joint ultrasonography may contribute to the evaluation of ICI-induced polyarthritis and monitoring the effects of treatments.